357 related articles for article (PubMed ID: 14640983)
21. Fine mapping and regulation of the association of p53 with p34cdc2.
Wagner P; Fuchs A; Götz C; Nastainczyk W; Montenarh M
Oncogene; 1998 Jan; 16(1):105-11. PubMed ID: 9467949
[TBL] [Abstract][Full Text] [Related]
22. Precise characterisation of monoclonal antibodies to the C-terminal region of p53 protein using the PEPSCAN ELISA technique and a new non-radioactive gel shift assay.
Pospísilová S; Brázda V; Amrichová J; Kamermeierová R; Palecek E; Vojtesek B
J Immunol Methods; 2000 Apr; 237(1-2):51-64. PubMed ID: 10725451
[TBL] [Abstract][Full Text] [Related]
23. Requirements for p53 and the ATM gene product in the regulation of G1/S and S phase checkpoints.
Xie G; Habbersett RC; Jia Y; Peterson SR; Lehnert BE; Bradbury EM; D'Anna JA
Oncogene; 1998 Feb; 16(6):721-36. PubMed ID: 9488036
[TBL] [Abstract][Full Text] [Related]
24. Regulation of the p53 protein by protein kinase C alpha and protein kinase C zeta.
Youmell M; Park SJ; Basu S; Price BD
Biochem Biophys Res Commun; 1998 Apr; 245(2):514-8. PubMed ID: 9571186
[TBL] [Abstract][Full Text] [Related]
25. PKCeta associates with cyclin E/cdk2/p21 complex, phosphorylates p21 and inhibits cdk2 kinase in keratinocytes.
Kashiwagi M; Ohba M; Watanabe H; Ishino K; Kasahara K; Sanai Y; Taya Y; Kuroki T
Oncogene; 2000 Dec; 19(54):6334-41. PubMed ID: 11175348
[TBL] [Abstract][Full Text] [Related]
26. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.
Yin MB; Guo B; Panadero A; Frank C; Wrzosek C; Slocum HK; Rustum YM
Exp Cell Res; 1999 Feb; 247(1):189-99. PubMed ID: 10047461
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of mutant p53 phosphorylation at serine 15 or serine 315 partially restores the function of wild-type p53.
Sugikawa E; Yazaki N; Tsunoda S; Nakanishi N; Ohashi M
Biochem Biophys Res Commun; 1999 Aug; 261(2):256-63. PubMed ID: 10425175
[TBL] [Abstract][Full Text] [Related]
28. Characterization of p21Cip1/Waf1 peptide domains required for cyclin E/Cdk2 and PCNA interaction.
Chen IT; Akamatsu M; Smith ML; Lung FD; Duba D; Roller PP; Fornace AJ; O'Connor PM
Oncogene; 1996 Feb; 12(3):595-607. PubMed ID: 8637717
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells.
Park US; Park SK; Lee YI; Park JG; Lee YI
Oncogene; 2000 Jul; 19(30):3384-94. PubMed ID: 10918595
[TBL] [Abstract][Full Text] [Related]
30. Cooperative phosphorylation at multiple sites is required to activate p53 in response to UV radiation.
Kapoor M; Hamm R; Yan W; Taya Y; Lozano G
Oncogene; 2000 Jan; 19(3):358-64. PubMed ID: 10656682
[TBL] [Abstract][Full Text] [Related]
31. Protein kinase CK2-dependent regulation of p53 function: evidence that the phosphorylation status of the serine 386 (CK2) site of p53 is constitutive and stable.
McKendrick L; Milne D; Meek D
Mol Cell Biochem; 1999 Jan; 191(1-2):187-99. PubMed ID: 10094408
[TBL] [Abstract][Full Text] [Related]
32. Regulation of the cryptic sequence-specific DNA-binding function of p53 by protein kinases.
Hupp TR; Lane DP
Cold Spring Harb Symp Quant Biol; 1994; 59():195-206. PubMed ID: 7587070
[TBL] [Abstract][Full Text] [Related]
33. Modulation of p53 binding to Holliday junctions and 3-cytosine bulges by phosphorylation events.
Subramanian D; Griffith JD
Biochemistry; 2005 Feb; 44(7):2536-44. PubMed ID: 15709766
[TBL] [Abstract][Full Text] [Related]
34. The carboxy terminus of p53 mimics the polylysine effect of protein kinase CK2-catalyzed MDM2 phosphorylation.
Guerra B; Götz C; Wagner P; Montenarh M; Issinger OG
Oncogene; 1997 Jun; 14(22):2683-8. PubMed ID: 9178766
[TBL] [Abstract][Full Text] [Related]
35. Protein kinase CK2 is involved in G2 arrest and apoptosis following spindle damage in epithelial cells.
Sayed M; Pelech S; Wong C; Marotta A; Salh B
Oncogene; 2001 Oct; 20(48):6994-7005. PubMed ID: 11704824
[TBL] [Abstract][Full Text] [Related]
36. Functional interaction of Puralpha with the Cdk2 moiety of cyclin A/Cdk2.
Liu H; Barr SM; Chu C; Kohtz DS; Kinoshita Y; Johnson EM
Biochem Biophys Res Commun; 2005 Mar; 328(4):851-7. PubMed ID: 15707957
[TBL] [Abstract][Full Text] [Related]
37. The development of a CDK2-docking site peptide that inhibits p53 and sensitizes cells to death.
Ferguson M; Luciani MG; Finlan L; Rankin EM; Ibbotson S; Fersht A; Hupp TR
Cell Cycle; 2004 Jan; 3(1):80-9. PubMed ID: 14657672
[TBL] [Abstract][Full Text] [Related]
38. DNA alkylation-induced phosphorylation of p53 and activation of kinases in colon cancer cells.
Jaiswal AS; Narayan S
Int J Oncol; 2001 Sep; 19(3):613-6. PubMed ID: 11494044
[TBL] [Abstract][Full Text] [Related]
39. PKC-zeta-associated CK2 participates in the turnover of free IkappaBalpha.
Bren GD; Pennington KN; Paya CV
J Mol Biol; 2000 Apr; 297(5):1245-58. PubMed ID: 10764587
[TBL] [Abstract][Full Text] [Related]
40. Casein kinase 2 inhibits the renaturation of complementary DNA strands mediated by p53 protein.
Filhol O; Baudier J; Chambaz EM; Cochet C
Biochem J; 1996 May; 316 ( Pt 1)(Pt 1):331-5. PubMed ID: 8645226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
